What is EnChroma?
EnChroma operates at the intersection of optical science and human-centric design, specializing in advanced eyewear engineered to address color vision deficiencies. The company provides a comprehensive suite of products, including outdoor, indoor, and prescription lenses, specifically calibrated to assist individuals with red-green color blindness. Beyond its consumer-facing product line, EnChroma has established a significant footprint in the accessibility market through its color accessibility program, which provides educational resources and infrastructure support for public and private institutions. By targeting a global demographic of approximately 350 million people, the company has transitioned from a niche innovator to a critical provider of life-enhancing optical tools, effectively bridging the gap between clinical vision science and everyday accessibility.
How much funding has EnChroma raised?
EnChroma has raised a total of $762K across 2 funding rounds:
Debt
$350K
Debt
$412K
Debt (2020): $350K with participation from PPP
Debt (2021): $412K led by PPP
Key Investors in EnChroma
PPP
Public-Private Partnership
What's next for EnChroma?
With the recent infusion of capital, EnChroma is well-positioned to scale its operational capacity and expand its reach within the global healthcare and accessibility markets. The strategic focus will likely shift toward deepening its research and development pipeline to refine lens technology while simultaneously broadening its distribution channels. As the company matures, the integration of its color accessibility programs into broader public infrastructure will be a key driver for long-term value creation. By maintaining its commitment to evidence-based optical solutions, EnChroma is poised to capture further market share, reinforcing its status as a leader in the assistive technology landscape and setting a new standard for inclusive design in the optical industry.
See full EnChroma company page
